breast cancer research

A metastatic breast cancer drug, discovered in the McDonnell Lab, is now FDA-approved—the first new oral endocrine therapy in 20+ years. Another might not be so far behind.

Duke Fencing students are asking the community to Fence4TheFight against breast cancer, in memory of their long-time manager Elizabeth Beguinet.

The hybrid retreat showcased the latest gastric cancer, blood cancer, pediatric sarcoma, glioblastoma, breast cancer, and immune micro-environment research.

Learn about some notable BRPC/DCI cancer research collaborations and why the partnership is core to winning big grants for cancer research.

Researchers mapping a molecular atlas for ductal carcinoma in situ have developed a predictive model to distinguish which cases will progress.

"What's Best For Breasts? A Conversation with Clinicians" was held online, Oct. 8. Topics included imaging, genetic testing, breast cancer risk, research, survivorship, and more.

John Wayne Cancer Foundation is funding research by breast surgical oncologist Maggie DiNome, MD, to create a molecular-based way to predict cancer spread to lymph nodes.
 

DCI cardio-oncologist Susan Dent, MD, is lead investigator for DCI-enrolled patients in this NIH-funded multi-site breast cancer study.

A DCI study led by Shelley Hwang, MD, MPH, shows the potential of new imaging technology to help avoid repeat surgery after lumpectomy.

Achieving health through advocacy, Duke Consortium for Inflammatory Breast Cancer expands its community outreach with Duke students taking the lead.

DCI study led by Gayathri Devi, PhD, finds chronic stresses such as racism and poverty alter cellular functions that promote tumor growth and proliferation

DCI teams raised more than $12,000 for the Susan G. Komen Foundation at the Komen Triangle Race for the Cure on April 30.

DCI pathologist Jeffrey Marks, PhD, has been named "Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery."

Donald McDonnell, PhD, associate director for Translational Research, DCI, receives prestigious St. Patrick's Day Irish science medal for contributions to academia and industry.

About one in seven breast cancers detected by mammography screening are over-diagnosed, according to a Duke Cancer Institute study

Susan Dent, MD, FRCPC, associate director, Clinical Research, DCI Breast Cancer Disease Group, has joined the Duke IBC Consortium as clinical director.

The grandfather of breast surgical oncologist Hannah Woriax, MD, was the first Native American to graduate from the Duke Med School and train in Family Medicine.

On Feb. 2 at noon, the Southeastern American Indian Cancer Health Equity Partnership hosts DCI breast surgeon Hannah Woriax, MD, for a virtual lecture (with CME credit available).

There's nothing like cancer, many survivors say, to remind you that nothing is guaranteed. Good or bad. Renee Garber got an unexpected "bonus year."

Former Blue Devil Maggie DiNome, MD, a breast surgical oncologist, joined Duke from UCLA as medical director of Wake County Breast Cancer Services and as a professor of Surgery.

The 8^th Annual DCI Scientific Retreat will be held via Zoom on Friday, Dec. 3, 2021 from 12:30 p.m. to 5 p.m. Keynote: UCSF's Alan Ashworth, PhD, FRS.

The metastatic breast cancer research grants, made possible by Susan G. Komen, bring together patient advocates and DCI & UNC Lineberger investigators.

"What's Best For Breasts? A Conversation with Duke Clinicians" was held online on Oct. 2. Topics included imaging, genetic testing, breast cancer risk assessment & prevention.

The gloves are on in the fight against breast cancer. See you at sunrise, Oct. 23 !

New study on cholesterol and breast cancer finds link between high cholesterol and worsening cancer spread.

Shelley Hwang, MD, vice chair of Research in the Department of Surgery, is renowned for her work in pre-invasive breast cancer.

Donald McDonnell, PhD, has been awarded a $600K Susan G. Komen Grant to study a potential new treatment for metastatic ER-positive breast cancer.

After 32 years with the Duke Cancer Institute family, breast medical oncologist P. Kelly Marcom, MD, retired from clinical practice at the end of May.

DCI oncologists and researchers are supporting the Komen mission “for a cure” — fighting breast cancer on all fronts. Learn about their research.

This OHE-hosted talk featured director of the Patierno/George/Freedman Lab Jennifer Freedman, PhD, and postdocs Tyler Allen, PhD, and Sean Piwarski, PhD.

The 2021 (virtual) Triangle Race for the Cure, presented by DCI, will be held on May 1, but there are many fun activities to try in April to support the cause.

In the age of Covid, Community Outreach & Engagement at DCI comes of age, team expands with disparities researcher/associate director

DCI investigators are invited to attend the Inaugural Metastatic Breast Cancer Collaborative Research Virtual Summit.

Susan Dent, MD, co-director of the Duke Cardio-Oncology Program, is a leading international expert in the field. She is also associate director of Clinical Research in DCI's Breast Program.

Can focusing on the immune system eradicate breast cancer?

The journey of a new drug for advanced breast cancer.

A breast cancer researcher's study of estrogen action may lead to better treatments for other cancers.

Breast cancer survivor Katrina Cooke has become a professional speaker, peer mentor, and advocate.

You can count on one hand the number of times a young graduate student finds a drug, then the drug is patented, licensed, and in a phase 2 trial within a couple years.

The American Cancer Society has a long history of awarding grants to DCI researchers as they work to better understand the complexities of cancer and develop new treatments.

Carey Anders, MD, and immunology researchers Erika Crosby, PhD, Zachary Hartman, PhD, among featured speakers at the national Komen MBC webinar series.

Komen scholar Donald McDonnell, PhD, spoke about the importance of investing in breast cancer research at MBC gala that raised $150K.

Katrina Cooke has beaten the odds; surviving nearly nine years with metastatic breast cancer. Giving of her time to make things better for others has been her lifeline.

Donald McDonnell, PhD, has been recognized for his leadership in estrogen receptor biology by Susan G. Komen with a Brinker Award for Scientific Distinction in Basic Science.
 

For the 19th year, DCI was local presenting sponsor for Komen NCTC's Triangle Race for the Cure, held Sept. 12. Team DCI raised spirits and funds.

Join Team DCI and turn your miles walked into dollars raised throughout the month of October, then join the virtual National Celebration on October 18.

Komen NCTC hosts its first annual gala to support metastatic breast cancer research; a virtual event with speakers, auctions, and treats on Saturday, October 10, at 7 p.m.

SAVE THE DATE: "What's Best For Breasts? A Conversation with Duke Clinicians" will be held online-only on Saturday, Sept. 19.

A new approach to training computational models on biological processes provides insights into how and why cancer cells metastasize to certain areas of the vasculature.

A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at DCI is part of an effective, two-drug strategy for enlisting the immune system to fight tumors.